Read Larry Connors' blog – Short Term Trading Strategies
Cardiome Pharma Corp. (NASDAQ: CRME | Quote | Chart | News | PowerRating) through its subsidiaries, operates as a life sciences company that focuses on developing drugs to treat or prevent cardiovascular diseases. The company's lead product includes Vernakalant (iv), a product candidate designed for the treatment of atrial fibrillation following cardiac surgery. It also offers and Vernakalant (oral), a product candidate, which is in Phase 2b clinical study for the prevention of recurrence of atrial fibrillation. It also involves in pre-clinical research and development work on the Artesian projects to attenuate the deleterious effects of the excessive neurohormonal activation that occurs in cardiac dysfunction. Cardiome Pharma Corp. has collaboration and license agreement with Astellas Pharma US, Inc. for the co-development and commercialization of Vernakalant as an intravenous formulation; and an in-licensing agreement with Lilly to develop GED-aPC, an engineered analog of recombinant human activated protein C for cardiogenic shock. The company was founded in 1986. It was formerly known as Nortran Resources, Ltd. and changed its name to Nortran Pharmaceuticals, Inc. in 1992. Further, the company changed its name to Cardiome Pharma Corp. in 2001. Cardiome Pharma is headquartered in Vancouver, Canada. With 63.73 million shares outstanding and 4.74 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of CRME. According to quarterly data provided by the SEC, there were still 21,228 shares of CRME that were failing-to-deliver as of September 14, 2007.
Flamel Technologies S.A. (NASDAQ: FLML | Quote | Chart | News | PowerRating) a biopharmaceutical company, develops polymer-based drug delivery technologies for the improvement of medical applications in France. It offers Interferon-Alpha XL, an interferon-alpha 2b for the treatment of hepatitis C virus and various oncology applications; FT-105, a long-acting basal insulin formulation for diabetic patients; and Interleukin-2 for the treatment of renal cancer. The company also provides Coreg CR, an extended release formulation of carvedilol phosphate for use in the treatment of congestive heart failure, left ventricular dysfunction following myocardial infarction, and hypertension; and Asacard162.5mg, a controlled release formulation of aspirin designed to provide therapy for cardiovascular treatment. The company has strategic alliances with GlaxoSmithKline, Merck Serono, Wyeth Pharmaceuticals, TAP Pharmaceuticals, Ltd., Bristol-Myers Squibb, Biovail, Servier, Merck & Co., Corning S.A., Corning Incorporated, and Corning Europe, Inc. Flamel Technologies was founded in 1990 and is headquartered in Venissieux, France. With 24.05 million shares outstanding and 4.36 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of FLML. According to quarterly data provided by the SEC, there were still 18,780 shares of FLML that were failing-to-deliver as of September 27, 2007.
First South Bancorp Inc (NASDAQ: FSBK | Quote | Chart | News | PowerRating) operates as the holding company for First South Bank that provides commercial banking services in North Carolina. It generates various deposit products, including checking accounts, money market accounts, statement savings accounts, individual retirement accounts, and certificates of deposit. The company also originates loan products, such as residential mortgage loans, including single-family residential, multi-family residential, and construction loans; commercial loans and leases for commercial real estate, commercial construction, commercial business, and lease receivables; consumer loans comprising automobile, savings account loans, certificate of deposit loans, home equity loans, and unsecured loans; and loans secured by first mortgages on owner-occupied, single-family residences. As of April 15, 2008, it operated 30 full service branch offices and 2 loan production offices in North Carolina. The company was founded in 1959 and is headquartered in Washington, North Carolina. With 9.75 million shares outstanding and 1.12 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of FSBK. According to quarterly data provided by the SEC, there were still 28,575 shares of FSBK that were failing-to-deliver as of September 28, 2007.
GMX Resources Inc. (NASDAQ: GMXR | Quote | Chart | News | PowerRating) together with its subsidiaries, engages in the acquisition, exploration, and development of properties for the production of crude oil and natural gas in Texas, Louisiana, and New Mexico. The company's drilling, development, and production activities primarily focus on the Cotton Valley Sands in the Sabine Uplift of the Carthage, North Field of Harrison and Panola counties of east Texas. As of December 31, 2007, it had proved reserves of 434.5 billion cubic feet of natural gas equivalent and 167 net producing wells. GMX Resources, Inc. also has a joint development agreement with Penn Virginia Oil & Gas, L.P. for the development of properties. The company was founded in 1998 and is headquartered in Oklahoma City, Oklahoma. With 16.52 million shares outstanding and 2.02 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of GMXR. According to quarterly data provided by the SEC, there were still 11,092 shares of GMXR that were failing-to-deliver as of September 27, 2007.
LCAVision Inc. (NASDAQ: LCAV | Quote | Chart | News | PowerRating) provides fixed-site laser vision correction services at its LasikPlus vision centers. The company's vision centers provide staff, facilities, equipment, and support services for performing laser vision correction that employ laser technologies to correct nearsightedness, farsightedness, and astigmatism. These vision centers are supported primarily by independent ophthalmologists and optometrists, as well as other health care professionals. The Ophthalmologists perform the laser vision correction procedures in its vision centers, and either ophthalmologists or optometrists conduct preprocedure evaluations and post-operative follow-ups in-center. As of July 15, 2008, it owned and operated 77 LasikPlus vision centers in 33 states serving 58 markets in the United States and a joint venture in Canada. The company was founded in 1985 and is headquartered in Cincinnati, Ohio. With 18.52 million shares outstanding and 9.23 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of LCAV. According to quarterly data provided by the SEC, there were still 57,517 shares of LCAV that were failing-to-deliver as of September 28, 2007.
SuccessFactors Inc. (NASDAQ: SFSF | Quote | Chart | News | PowerRating) provides on-demand performance and talent management software that enable organizations to optimize the performance of their people. Its application suite includes various modules and capabilities, including performance management, goal management, compensation management, succession management, learning and development, recruiting management, analytics and reporting, employee profile, 360-degree review, employee survey, and proprietary and third-party content. The company also provides configuration and implementation services, as well as follow-on services, including end-user training and business transformation services. SuccessFactors offers its products to large enterprises, as well as to small and mid-sized businesses operating in various industries, such as consumer, energy, financial services, government, healthcare, life sciences, manufacturing, retail, telecommunications and technology, and transportation. It operates primarily in North America, Latin America, Europe and the Middle East, and Asia-Pacific. The company was founded in 2001 as Success Acquisition Corporation and changed its name to SuccessFactors, Inc. in 2007. SuccessFactors, Inc. is headquartered in San Mateo, California. With 52.42 million shares outstanding and 3.04 million shares declared short as of July 2008, there is no longer a failure to deliver in shares of SFSF.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 2,100,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
The Connors Group, Inc. ("Company") is not an investment advisory service, nor a registered investment advisor or broker-dealer and does not purport to tell or suggest which securities or currencies customers should buy or sell for themselves. The analysts and employees or affiliates of Company may hold positions in the stocks, currencies or industries discussed here. You understand and acknowledge that there is a very high degree of risk involved in trading securities and/or currencies. The Company, the authors, the publisher, and all affiliates of Company assume no responsibility or liability for your trading and investment results. Factual statements on the Company's website, or in its publications, are made as of the date stated and are subject to change without notice.
It should not be assumed that the methods, techniques, or indicators presented in these products will be profitable or that they will not result in losses. Past results of any individual trader or trading system published by Company are not indicative of future returns by that trader or system, and are not indicative of future returns which be realized by you. In addition, the indicators, strategies, columns, articles and all other features of Company's products (collectively, the "Information") are provided for informational and educational purposes only and should not be construed as investment advice. Examples presented on Company's website are for educational purposes only. Such set-ups are not solicitations of any order to buy or sell. Accordingly, you should not rely solely on the Information in making any investment. Rather, you should use the Information only as a starting point for doing additional independent research in order to allow you to form your own opinion regarding investments. You should always check with your licensed financial advisor and tax advisor to determine the suitability of any investment.
HYPOTHETICAL OR SIMULATED PERFORMANCE RESULTS HAVE CERTAIN INHERENT LIMITATIONS. UNLIKE AN ACTUAL PERFORMANCE RECORD, SIMULATED RESULTS DO NOT REPRESENT ACTUAL TRADING AND MAY NOT BE IMPACTED BY BROKERAGE AND OTHER SLIPPAGE FEES. ALSO, SINCE THE TRADES HAVE NOT ACTUALLY BEEN EXECUTED, THE RESULTS MAY HAVE UNDER- OR OVER-COMPENSATED FOR THE IMPACT, IF ANY, OF CERTAIN MARKET FACTORS, SUCH AS LACK OF LIQUIDITY. SIMULATED TRADING PROGRAMS IN GENERAL ARE ALSO SUBJECT TO THE FACT THAT THEY ARE DESIGNED WITH THE BENEFIT OF HINDSIGHT. NO REPRESENTATION IS BEING MADE THAT ANY ACCOUNT WILL OR IS LIKELY TO ACHIEVE PROFITS OR LOSSES SIMILAR TO THOSE SHOWN.
The Connors Group, Inc.
15260 Ventura Blvd., Ste. 2200
Sherman Oaks, CA 91403
© Copyright 2009 The Connors Group, Inc.
